Chengliang Dai

机构：Fudan University, NIHR Imperial Biomedical Research Centre, Zhongshan Hospital, UCB Pharma (United Kingdom), Biopharma Technology (United Kingdom), Imperial College London, UCB Pharma (Belgium) · ORCID：0000-0002-9931-5437

发表论文 41 篇 · 总被引 753 次 · h-index 14

代表论文

• QU-BraTS: MICCAI BraTS 2020 Challenge on Quantifying Uncertainty in Brain Tumor Segmentation – Analysis of Ranking Scores and Benchmarking Results (2022 · The Journal of Machine Learning for Biomedical Imaging · 被引 56)
• A hybrid framework with large language models for rare disease phenotyping (2024 · BMC Medical Informatics and Decision Making · 被引 29)
• Suggestive Annotation of Brain Tumour Images with Gradient-Guided Sampling (2020 · Lecture notes in computer science · 被引 28)
• Automatic Brain Tumour Segmentation and Biophysics-Guided Survival Prediction (2020 · Lecture notes in computer science · 被引 25)
• Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective (2024 · British Journal of Dermatology · 被引 22)
• The Extreme Cardiac MRI Analysis Challenge under Respiratory Motion (CMRxMotion) (2022 · arXiv (Cornell University) · 被引 13)